glp-1 and sibo Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis GLP-1 & SIBO | Your

Description

What's in it

Probiotic and prebiotic supplements work best as part of a comprehensive health strategy that includes balanced nutrition, healthy lifestyle habits, and appropriate medical care when needed

Learn how GLP1 medication relates to midlife weight gain, HRT, muscle loss, appetite, side effects and long-term weight maintenance.

A spoon is lifting some of the soup from the bowl

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020